Subscribe to The St. Louis American‘s free weekly newsletter for critical stories, community voices, and insights that matter. Sign up When Dr. Ambroise Wonkam walked into a panel on medical genetics ...

Most individuals living with sickle cell disease who presented to the emergency department with a pain crisis, known as vaso-occlusive crisis (VOC), were not triaged appropriately according to ...

Learn the fundamental skill of equipment maintenance. This video walks you through the easy process of replacing the sickle bar, ensuring your machine performs at peak efficiency. EU threatens Britain ...

Logan and Erin Dorsey, who fought sickle cell anemia for 11 years, are now nurses at the University of Mississippi Medical Center, using their experiences to help others."Without God's grace, we ...

ORLANDO, Fla. — Central Florida’s Sickle Cell Conquerors hosted their first-ever Sickle Cell Walk at Carver Middle School in Orlando to increase awareness and support for sickle cell disease. Sickle ...

In Ghana newborn screening for sickle cell disease is rare, with many children going undiagnosed until painful symptoms force emergency care. The International Sickle Cell Centre (ISCC), a nonprofit ...

MOBILE, Ala. (WALA) - National Sickle Cell Awareness Month is here, and Mobile is hosting several events to educate, support, and raise awareness. Gerald Alfred, Executive Director of the Sickle Cell ...

OMAHA, Neb. (WOWT) - Nobel Prize-winning technology offers a potential cure for sickle cell disease. Simply put, doctors can edit a patient’s genes to alter blood cells. But this gene editing ...

(WAVY) — Just one year after Gov. Glenn Youngkin passed HB 252 into law, mandating the creation of a statewide sickle cell registry, the Virginia Department of Health has begun launching its first ...

Aug 15 (Reuters) - In the latest setback for Pfizer's (PFE.N), opens new tab sickle cell anemia treatments, experimental drug inclacumab failed to meet the main goal in a late-stage trial for patients ...

Pfizer Inc. (NYSE:PFE) on Friday released results from the Phase 3 THRIVE-131 study evaluating inclacumab, an investigational P-selectin inhibitor, in patients 16 years of age and older with sickle ...

This story is the first in an occasional series following Louisiana’s first patients to receive gene therapy for sickle cell disease. On the third floor of Manning Family Children’s Hospital in New ...